Stocks kept sinking up until the market close Thursday, as the major indexes finished near session lows and a postelection ...

Linda Winston decided after over two decades being a patient dealing with Crohn’s disease, she wanted to become an advocate ...

Griffon shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 64 to 88.

P13, a biosimilar of infliximab, in inflammatory bowel diseases: a systematic review and meta-analysis," published in the November 2024 issue of Gastroenterology by Hu et al. Since 2015, CT-P13, a ...

Yes, kidney stones can cause gastrointestinal (GI) problems, such as bloating, diarrhea, and constipation. This article ...

Nanoparticles that turn inflammation into propulsion power deliver targeted IBD treatment, enhancing precision and efficacy.

Many patients with IBD report persisting symptoms, despite resolution of the inflammatory process. Although by definition, a ...

The biomarker assay can be used potentially to enrich clinical trials and monitor patients' disease activity and treatment response.

A randomized controlled trial finds no clear benefit of adding bezlotoxumab to FMT in patients with IBD and recurrent C difficile infection.

Developing a vaccination program for infectious bursal disease virus (IBDV) challenges should consider the severity and ...

Aeglea Biotherapeutics Inc. ( (SYRE) ) has released its Q3 earnings. Here is a breakdown of the information Aeglea Biotherapeutics Inc.

Alcohol can worsen Crohn’s disease symptoms, but the impact varies from person to person. It may depend on what and how much ...